>
Organization
Halozyme Therapeutics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Halozyme Therapeutics, Inc.

... Halozyme has dropped the progression-free survival (PFS) co-primary endpoint from its phase 3 ...
... PR Newswire Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today ...
... SAN DIEGO - Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today ...
... PR Newswire Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today ...
... Halozyme Therapeutics' Phase III HALO-301 trial investigating PEGPH20 for first-line pancreatic cancer with ...
... PR Newswire Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today ...
... Roche and Halozyme are at it again—12 years after their initial collaboration around the latter's ...
... SAN DIEGO - Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Bristol-Myers Squibb (NYSE: BMY) has dosed the ...
... PR Newswire Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the presentation of data from two clinical trials ...
Subscribe now for full coverage on Halozyme Therapeutics, Inc.
Start My Free Trial